Molecular changes in the brain in aftermath of traumatic event may help explain long-term susceptibility or resilience

by Medical College of Georgia at Augusta UniversityDr. Chung Sub Kim. Credit: Michael Holahan, Augusta UniversitySocial avoidance is a common symptom of PTSD, and scientists working to better und

Updated on: February 05,2024

Molecular changes in the brain in aftermath of traumatic event may help explain long-term susceptibility or resilience

by Medical College of Georgia at Augusta UniversityDr. Chung Sub Kim. Credit: Michael Holahan, Augusta UniversitySocial avoidance is a common symptom of PTSD, and scientists working to better und

Updated on:February 05,2024

Racial differences in Alzheimer's disease unveiled

by Washington University School of MedicineCredit: CC0 Public DomainAfrican-Americans may be twice as likely as Caucasian Americans to develop Alzheimer's disease, but nobody knows why becaus

Updated on: April 08,2024

Racial differences in Alzheimer's disease unveiled

by Washington University School of MedicineCredit: CC0 Public DomainAfrican-Americans may be twice as likely as Caucasian Americans to develop Alzheimer's disease, but nobody knows why becaus

Updated on:April 08,2024

Small brains can accomplish big things, according to new theoretical research

Small brains can accomplish big things, according to new theoretical researchbyHoward Hughes Medical InstituteA biological attractor network overcomes hypothesized limitations of discreteness. C

Updated on: October 18,2024

Small brains can accomplish big things, according to new theoretical research

Small brains can accomplish big things, according to new theoretical researchbyHoward Hughes Medical InstituteA biological attractor network overcomes hypothesized limitations of discreteness. C

Updated on:October 18,2024

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

by Frederic Calon and Étienne Aumont,The ConversationCredit: AI-generated imageOn Nov. 30, Eisai and Biogen announced theresults of their latest phase 3 clinical trial in Alzheimer's d

Updated on: March 30,2024

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

by Frederic Calon and Étienne Aumont,The ConversationCredit: AI-generated imageOn Nov. 30, Eisai and Biogen announced theresults of their latest phase 3 clinical trial in Alzheimer's d

Updated on:March 30,2024

How do we decide what to look at next? A computational model has the answer

byTechnical University of BerlinObject-based scanpath simulation in dynamic scenes. Credit: The image is derived from a frame of the field03 video of the VidCom dataset (Permission to Publish Co

Updated on: January 11,2024

How do we decide what to look at next? A computational model has the answer

byTechnical University of BerlinObject-based scanpath simulation in dynamic scenes. Credit: The image is derived from a frame of the field03 video of the VidCom dataset (Permission to Publish Co

Updated on:January 11,2024

Study identifies new biomarkers of Alzheimer's disease

by Ingrid Fadelli , Medical XpressStudy overview. Credit:Nature Human Behaviour(2024). DOI: 10.1038/s41562-024-01924-6Recent advances in the study of proteomes (i.e., the entire range of p

Updated on: July 31,2024

Study identifies new biomarkers of Alzheimer's disease

by Ingrid Fadelli , Medical XpressStudy overview. Credit:Nature Human Behaviour(2024). DOI: 10.1038/s41562-024-01924-6Recent advances in the study of proteomes (i.e., the entire range of p

Updated on:July 31,2024

Risk factors for faster aging in the brain revealed in new study

by University of OxfordTo the left of the figure, the red-yellow color denotes the regions that degenerate earlier than the rest of the brain, and are vulnerable to Alzheimer's disease. These

Updated on: March 30,2024

Risk factors for faster aging in the brain revealed in new study

by University of OxfordTo the left of the figure, the red-yellow color denotes the regions that degenerate earlier than the rest of the brain, and are vulnerable to Alzheimer's disease. These

Updated on:March 30,2024

Researchers develop new brain network modeling tools to advance Alzheimer's disease research

by Indiana University School of MedicineCredit: CC0 Public DomainIndiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously dev

Updated on: February 24,2024

Researchers develop new brain network modeling tools to advance Alzheimer's disease research

by Indiana University School of MedicineCredit: CC0 Public DomainIndiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously dev

Updated on:February 24,2024

Depression in Alzheimer's has different risk factors than depression in those without dementia

by University of BristolGDS trajectory analysis in NACC (A). Individuals with persistent depressive symptoms during follow-up (group 5) appeared to have more apathy (C), anxiety (D), and NPI rate

Updated on: April 20,2024

Depression in Alzheimer's has different risk factors than depression in those without dementia

by University of BristolGDS trajectory analysis in NACC (A). Individuals with persistent depressive symptoms during follow-up (group 5) appeared to have more apathy (C), anxiety (D), and NPI rate

Updated on:April 20,2024

Connections between addictive drugs and brain function in mice

by John Spizzirri,Argonne National LaboratoryFigure 1. Experimental design for dopamine connectomics. (A) Adeno-associated viruses (AAVs) expressing Cre-dependent Apex2 were bilaterally injected

Updated on: February 05,2024

Connections between addictive drugs and brain function in mice

by John Spizzirri,Argonne National LaboratoryFigure 1. Experimental design for dopamine connectomics. (A) Adeno-associated viruses (AAVs) expressing Cre-dependent Apex2 were bilaterally injected

Updated on:February 05,2024

Neuralink shows quadriplegic playing chess with brain implant

Elon Musk's Neuralink startup designed a surgical robot to implant devices into brains to link them to computers.Neuralink on Wednesday streamed a video of its first human patient playing computer

Updated on: March 28,2024

Neuralink shows quadriplegic playing chess with brain implant

Elon Musk's Neuralink startup designed a surgical robot to implant devices into brains to link them to computers.Neuralink on Wednesday streamed a video of its first human patient playing computer

Updated on:March 28,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024